Clinical trial
Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy
NCT01422018 is registered in ClinicalTrials.gov with Seoul St. Mary's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy
- Lead sponsor
- Seoul St. Mary's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- February 29, 2012
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.